Click 
to remove filters
Pro-life groups ramped up their PR efforts this week to make plain their condemnation of human embryo research following the creation of the first embryonic human clone in the US. Political campaigners The ProLife Alliance and charity LIFE have been quick to put emergency media relations...
WARREN, NJ: Makovsky & Company will spearhead a campaign by pharmaceutical company Celgene to expand its controversial drug Thalidomide to European and Australian markets. Once banned in the US, the drug was given limited FDA approval in 1998 as a treatment for leprosy. More recently, however,...
The news this week that the NHS organisation responsible for communicating best practice procedure has itself sought PR help might alarm some. But with the outgoing president of the General Medical Council Sir Donald Irvine last week saying that patient demands are increasingly as exacting as...
GENEVA: The International Federation of Pharmaceutical Manufacturers has taken on APCO Worldwide to handle communications surrounding the global debate on medicine trade policy. APCO UK will oversee reputation management on the pan-European brief, which is to be co-ordinated by APCO's dedicated...
NEW YORK - Amazon.com's marketing chief David Risher is to leave the company next March after five years with the online retailer.
LONDON - Nikon has launched its first UK television advertising campaign in more than 10 years in support of its digital camera range in the run-up to the holiday season.
NEW YORK: Ketchum has won a PR brief for Novartis' yet-to-be-branded arthritis treatment. The agency beat Hill & Knowlton and Chamberlain Communications Group for the account to handle all communications in the US for the COX189 through the drug's launch. The drug is expected to become available...
BANGKOK: Independent firm Nine East has won its first healthcare client - Pfizer - and has launched a healthcare practice. Nine East will work for Pfizer's Viagra and Lipitor brands. The practice will be headed by former Shandwick Thai corporate group practice head Pongprach Surojnametakul.
Pharma giant GlaxoSmithKline's global corporate PR chief Geoff Potter is stepping down after 30 years with the company. Potter is to leave at the end of the month, handing over the role of senior vice-president, corporate communications and community partnerships to current IR boss Jennie...
Organisation: Bayer Issue: Supply of antibiotic Cipro to US Government It was hailed as the 'wonder drug of the anthrax scare' (The Times, 19/10) that had 'revitalised its moribund German manufacturer, Bayer' (The Independent, 23/10). But the supply of the powerful antibiotic, Cipro,...
